Zobrazeno 1 - 10
of 73
pro vyhledávání: '"E Mechetner"'
Publikováno v:
Russian Journal of General Chemistry. 84:345-356
Due to a unique structure of tumors, TNT antibodies can bind with a great number of target cells in the hypoxic core of the injury zone. Long-standing laboratory and clinical research gave evidence for the utility of histone/DNA complexes as stable i
Evidence for Multidrug Resistance-1 P-Glycoprotein-dependent Regulation of Cellular ATP Permeability
Autor:
Noureddine Lomri, E. Mechetner, Gavin M. Braunstein, Richard M. Roman, Amy K. Davison, L. A. Simeoni, Erik M. Schwiebert, Andrew P. Feranchak, J. G. Fitz
Publikováno v:
Journal of Membrane Biology. 183:165-173
The mechanisms responsible for regulating epithelial ATP permeability and purinergic signaling are not well defined. Based on the observations that members of the ATP-binding cassette (ABC)1 family of proteins may contribute to ATP release, the purpo
Autor:
Holzmayer Tatyana, Edward A. Levine, R Mera, T. K. Das Gupta, C Bolliger, E Mechetner, S Bacus, Igor B. Roninson
Publikováno v:
Scopus-Elsevier
PURPOSE In addition to tumor size, grade, location, and the presence of metastases, other factors may be useful in prognostication for adults with soft tissue sarcoma (STS). This study examines the relationship of MDR-1 mRNA, p-glycoprotein (P-gp), K
Publikováno v:
European journal of biochemistry. 268(8)
Conformational changes accompanying P-glycoprotein (Pgp) mediated drug transport are reflected by changes in the avidity of certain monoclonal antibodies (mAbs). More of the UIC2 mAb binds to Pgp-expressing cells in the presence of substrates or modu
Publikováno v:
Cancer detection and prevention. 24(5)
P-glycoprotein (P-gp) acts as an active efflux mechanism for a large number of cytostatics and seems to be involved in the frequent failure of cancer chemotherapy. The molecular events of substrate recognition and transport still are not understood c
Publikováno v:
Gynecologic Oncology. 107:377-378
2532 Background: To determine the biomarker expression and drug resistance patterns of undifferentiated ovarian cancers. Methods: Biomarker expression was determined by immunohistochemistry. In vitro drug resistance profiles were analyzed by assays e
Autor:
Z, Rahman, J, Kavanagh, R, Champlin, R, Giles, E, Hanania, S, Fu, Z, Zu, R, Mehra, F, Holmes, A, Kudelka, D, Claxton, C, Verschraegen, J, Gajewski, M, Andreeff, S, Heimfeld, R, Berenson, D, Ellerson, L, Calvert, E, Mechetner, T, Holzmayer, A, Dayne, J, Hamer, C, Bachier, J, Ostrove, A, Deisseroth
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 4(11)
Most patients relapse after high-dose chemotherapy (HDCT) with autologous stem-cell transplantation (ASCT) for metastatic breast cancer. Further chemotherapy immediately after hematopoietic recovery from ASCT is not given for fear of irreversibly dam
Publikováno v:
Blood. 88(6)
The cell-surface expression and the functional status of the CD95/Fas antigen on primitive hematopoietic progenitors (PHPs) freshly isolated from human fetal liver (FL) were studied. PHPs were phenotypically defined as CD34++ CD38 -/+ cells. The most
Autor:
L. Peterson, J. Ma, Marilyn K. Davis, Ossama Tawfik, Julia Chapman, E. Mechetner, R. Parker, Qamar J. Khan
Publikováno v:
Journal of Clinical Oncology. 25:16055-16055
16055 Background: The reliability of molecular biomarkers as predictors of treatment outcome remains unclear and, in relation to drug resistance even less is known. Immunohistochemical (IHC) expression of biomarkers and in vitro drug resistance (IVDR
Autor:
M. Patel, Sandeep Singh Grewal, E. Mechetner, R. Sehgal, C. Yee, B. Yestrepsky, R. Parker, Supriya K. Saha, Kimberly Barber, David Wiese
Publikováno v:
Journal of Clinical Oncology. 25:14509-14509
14509 Background: Lymph Node (LN) status is the most important prognostic factor in colon cancer (Cca). Angiogenesis Index (AI) has been studied as a prognostic marker in various solid tumors with conflicting results. Hence, a retrospective analysis